We stand behind our product and customer service
Recalls & Warnings November 29, 2012 Sensa Settles Second False Advertising Lawsuit On November 27, 2012, Sensa Products LLC, maker of the Sensa Weight Loss System, announced it agreed to settle a false advertising lawsuit filed by the Nutritional Supplemental Task Force in California, without an admission of guilt
Neurophysiol Clin
The leading edge of that market is driven by popular peptides in use by biohackers and longevity enthusiasts that range from the off-label use of GLP-1 agonists for Alzheimers prevention, to the newly FDA-approved mitochondrial therapeutic SS-31 (elamipretide), to popular grey market biohacker compounds like BPC-157 and Cerebrolysin
Recent studies involving randomized controlled trials showed that oral glutathione resulted in a significant reduction in the melanin index compared to placebo
Sold for laboratory research use only Alixa Pharma currently ships to eligible domestic addresses only